Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hegele

Showing results (141-150 of 846) with videos related to

Pageof 85
Sort By:
Critical Reviews in Clinical Laboratory Sciences|December 5, 2009
Predictive genetic testing for coronary artery diseaseChristopher T Johansen, Robert A Hegele
Current Opinion in Lipidology|April 26, 2021
Lipid effects of glucagon-like peptide 1 receptor analogsAmanda J Berberich, Robert A Hegele
The Journal of Clinical Endocrinology and Metabolism|May 29, 2012
Severe hypertriglyceridemia in pregnancyAlyse S Goldberg, Robert A Hegele
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 14, 2005
Genetic and physiological insights into the metabolic syndromeRobert A Hegele, Rebecca L Pollex
Best Practice & Research. Clinical Endocrinology & Metabolism|January 14, 2023
The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disordersAmanda J Berberich, Robert A Hegele
The Lancet. Diabetes & Endocrinology|November 1, 2020
Insulin's centenary: the birth of an ideaRobert A Hegele, Grant M Maltman
British Journal of Pharmacology|June 10, 2008
The failure of torcetrapib: what have we learned?T R Joy, R A Hegele
Expert Opinion on Investigational Drugs|October 28, 2016
Lomitapide for the treatment of hypertriglyceridemiaAmanda J Brahm, Robert A Hegele
Current Genetic Medicine Reports|March 14, 2017
Genetics of Lipid and Lipoprotein Disorders and TraitsJacqueline S Dron, Robert A Hegele
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Microsomal triglyceride transfer protein inhibition-friend or foe?Tisha R Joy, Robert A Hegele
Pageof 85

Showing results (141-150 of 846) with videos related to

Sort By:
Pageof 85
Critical Reviews in Clinical Laboratory Sciences|December 5, 2009
Predictive genetic testing for coronary artery diseaseChristopher T Johansen, Robert A Hegele
Current Opinion in Lipidology|April 26, 2021
Lipid effects of glucagon-like peptide 1 receptor analogsAmanda J Berberich, Robert A Hegele
The Journal of Clinical Endocrinology and Metabolism|May 29, 2012
Severe hypertriglyceridemia in pregnancyAlyse S Goldberg, Robert A Hegele
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|May 14, 2005
Genetic and physiological insights into the metabolic syndromeRobert A Hegele, Rebecca L Pollex
Best Practice & Research. Clinical Endocrinology & Metabolism|January 14, 2023
The advantages and pitfalls of genetic analysis in the diagnosis and management of lipid disordersAmanda J Berberich, Robert A Hegele
The Lancet. Diabetes & Endocrinology|November 1, 2020
Insulin's centenary: the birth of an ideaRobert A Hegele, Grant M Maltman
British Journal of Pharmacology|June 10, 2008
The failure of torcetrapib: what have we learned?T R Joy, R A Hegele
Expert Opinion on Investigational Drugs|October 28, 2016
Lomitapide for the treatment of hypertriglyceridemiaAmanda J Brahm, Robert A Hegele
Current Genetic Medicine Reports|March 14, 2017
Genetics of Lipid and Lipoprotein Disorders and TraitsJacqueline S Dron, Robert A Hegele
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Microsomal triglyceride transfer protein inhibition-friend or foe?Tisha R Joy, Robert A Hegele
Pageof 85